Cargando…

Establishment of a new bovine leukosis virus producing cell line

Due to the prevalence of different bovine leukosis virus (BLV) species in the cattle population in Europe, problems may arise in the serological diagnosis of BLV infections. In addition, earlier investigations demonstrated that contamination of the BLV antigen-producing cell culture systems by bovin...

Descripción completa

Detalles Bibliográficos
Autores principales: Beier, D., Riebe, R., Blankenstein, P., Starick, E., Bondzio, A., Marquardt, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112874/
https://www.ncbi.nlm.nih.gov/pubmed/15381362
http://dx.doi.org/10.1016/j.jviromet.2004.06.017
_version_ 1783513562228981760
author Beier, D.
Riebe, R.
Blankenstein, P.
Starick, E.
Bondzio, A.
Marquardt, O.
author_facet Beier, D.
Riebe, R.
Blankenstein, P.
Starick, E.
Bondzio, A.
Marquardt, O.
author_sort Beier, D.
collection PubMed
description Due to the prevalence of different bovine leukosis virus (BLV) species in the cattle population in Europe, problems may arise in the serological diagnosis of BLV infections. In addition, earlier investigations demonstrated that contamination of the BLV antigen-producing cell culture systems by bovine viral diarrhea virus (BVDV) may give rise to misinterpretation of serological test results after BVDV vaccination of cattle. By co-cultivation of peripheral leukocytes of a BLV-infected cow with a permanent sheep kidney cell line, a new BLV-producing cell line named PO714 was established. This line carries a BLV provirus of the Belgian species and has been tested to be free of a variety of possibly contaminating viruses and mycoplasms. Investigations of a panel of well-characterised sera by agar gel immunodiffusion (AGID) and capture ELISA (cELISA) tests using antigen prepared from this new cell line in comparison with antigen of the well-known cell line FLK/BLV yielded comparable results. False positive results caused by BVDV cross-reactions could be eliminated when tests were carried out with antigen derived from the new cell line.
format Online
Article
Text
id pubmed-7112874
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71128742020-04-02 Establishment of a new bovine leukosis virus producing cell line Beier, D. Riebe, R. Blankenstein, P. Starick, E. Bondzio, A. Marquardt, O. J Virol Methods Article Due to the prevalence of different bovine leukosis virus (BLV) species in the cattle population in Europe, problems may arise in the serological diagnosis of BLV infections. In addition, earlier investigations demonstrated that contamination of the BLV antigen-producing cell culture systems by bovine viral diarrhea virus (BVDV) may give rise to misinterpretation of serological test results after BVDV vaccination of cattle. By co-cultivation of peripheral leukocytes of a BLV-infected cow with a permanent sheep kidney cell line, a new BLV-producing cell line named PO714 was established. This line carries a BLV provirus of the Belgian species and has been tested to be free of a variety of possibly contaminating viruses and mycoplasms. Investigations of a panel of well-characterised sera by agar gel immunodiffusion (AGID) and capture ELISA (cELISA) tests using antigen prepared from this new cell line in comparison with antigen of the well-known cell line FLK/BLV yielded comparable results. False positive results caused by BVDV cross-reactions could be eliminated when tests were carried out with antigen derived from the new cell line. Elsevier B.V. 2004-11 2004-08-17 /pmc/articles/PMC7112874/ /pubmed/15381362 http://dx.doi.org/10.1016/j.jviromet.2004.06.017 Text en Copyright © 2004 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Beier, D.
Riebe, R.
Blankenstein, P.
Starick, E.
Bondzio, A.
Marquardt, O.
Establishment of a new bovine leukosis virus producing cell line
title Establishment of a new bovine leukosis virus producing cell line
title_full Establishment of a new bovine leukosis virus producing cell line
title_fullStr Establishment of a new bovine leukosis virus producing cell line
title_full_unstemmed Establishment of a new bovine leukosis virus producing cell line
title_short Establishment of a new bovine leukosis virus producing cell line
title_sort establishment of a new bovine leukosis virus producing cell line
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112874/
https://www.ncbi.nlm.nih.gov/pubmed/15381362
http://dx.doi.org/10.1016/j.jviromet.2004.06.017
work_keys_str_mv AT beierd establishmentofanewbovineleukosisvirusproducingcellline
AT rieber establishmentofanewbovineleukosisvirusproducingcellline
AT blankensteinp establishmentofanewbovineleukosisvirusproducingcellline
AT staricke establishmentofanewbovineleukosisvirusproducingcellline
AT bondzioa establishmentofanewbovineleukosisvirusproducingcellline
AT marquardto establishmentofanewbovineleukosisvirusproducingcellline